SONOMA PHARMACEUTICALS, INC. Cash and Cash Equivalents
SONOMA PHARMACEUTICALS, INC. (SNOA) had Cash and Cash Equivalents of $5.34 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $5.34M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $2.40M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $2.56M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $3.04M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $5.34M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.40M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $2.56M 10-Q · filed 2026-02-10 |
| 2025-09-30 | $3.04M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $3.60M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $5.37M 10-K · filed 2026-06-16 |
| 2024-12-31 | $5.24M 10-Q · filed 2025-02-05 |
| 2024-09-30 | $4.08M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.59M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $3.13M 10-K · filed 2025-06-17 |
| 2023-12-31 | $2.41M 10-Q · filed 2024-02-08 |
| 2023-09-30 | $2.14M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $3.54M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $3.82M 10-K · filed 2024-06-17 |
| 2022-12-31 | $2.63M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $3.35M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $5.59M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $7.40M 10-K · filed 2023-06-21 |
| 2021-12-31 | $8.53M 10-Q · filed 2022-02-11 |
| 2021-09-30 | $8.39M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.81M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $4.22M 10-K · filed 2022-07-13 |
| 2020-12-31 | $5.54M 10-Q · filed 2022-02-11 |
| 2020-09-30 | $4.32M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $4.55M 10-Q · filed 2021-08-16 |
| 2020-03-31 | $3.69M 10-Q · filed 2022-02-11 |
| 2019-12-31 | $3.73M 10-Q · filed 2021-02-16 |
| 2019-09-30 | $3.23M 10-Q · filed 2020-11-20 |
| 2019-06-30 | $4.28M 10-Q/A · filed 2020-11-17 |
| 2019-03-31 | $3.69M 10-K · filed 2021-07-14 |
| 2018-12-31 | $6.50M 10-Q · filed 2020-02-14 |
| 2018-09-30 | $4.05M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $7.68M 10-Q · filed 2019-08-13 |
| 2018-03-31 | $10.07M 10-K · filed 2020-07-10 |
| 2017-12-31 | $8.63M 10-Q · filed 2019-02-14 |
| 2017-09-30 | $9.98M 10-Q · filed 2018-11-08 |
| 2017-06-30 | $12.64M 10-Q · filed 2018-08-08 |
| 2017-03-31 | $17.46M 10-K · filed 2019-07-01 |
| 2016-12-31 | $18.98M 10-Q · filed 2018-02-14 |
| 2016-09-30 | $3.25M 10-Q · filed 2017-11-14 |
| 2016-06-30 | $4.97M 10-Q · filed 2017-08-08 |
| 2016-03-31 | $7.47M 10-K · filed 2018-06-26 |
| 2015-12-31 | $6.11M 10-Q · filed 2017-02-17 |
| 2015-09-30 | $7.97M 10-Q · filed 2016-11-15 |
| 2015-06-30 | $8.75M 10-Q · filed 2016-08-09 |
| 2015-03-31 | $6.14M 10-K · filed 2017-06-28 |
| 2014-12-31 | $2.24M 10-Q · filed 2016-02-16 |
| 2014-09-30 | $3.55M 10-Q · filed 2015-11-10 |
| 2014-06-30 | $4.99M 10-Q · filed 2015-08-07 |
| 2014-03-31 | $5.48M 10-K · filed 2016-06-21 |
| 2013-12-31 | $3.44M 10-Q · filed 2015-02-12 |
| 2013-09-30 | $3.19M 10-Q · filed 2014-11-13 |
| 2013-06-30 | $5.38M 10-Q · filed 2014-08-12 |
| 2013-03-31 | $7.90M 10-K · filed 2015-06-16 |
| 2012-12-31 | $6.60M 10-Q · filed 2014-02-14 |
| 2012-09-30 | $8.31M 10-Q · filed 2013-11-19 |
| 2012-06-30 | $4.40M 10-Q · filed 2013-08-14 |
| 2012-03-31 | $3.35M 10-K · filed 2014-06-30 |
| 2011-12-31 | $4.96M 10-Q · filed 2013-02-13 |
| 2011-09-30 | $3.62M 10-Q · filed 2012-11-08 |
| 2011-06-30 | $5.03M 10-Q/A · filed 2012-08-31 |
| 2011-03-31 | $4.37M 10-K · filed 2013-06-25 |
| 2010-12-31 | $4.67M 10-Q · filed 2012-02-10 |
| 2010-09-30 | $5.37M 10-Q · filed 2011-11-03 |
| 2010-06-30 | $6.67M 10-Q/A · filed 2011-08-09 |
| 2010-03-31 | $6.26M 10-K · filed 2012-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |